Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis (Phase2b)
|ClinicalTrials.gov Identifier: NCT03538951|
Recruitment Status : Unknown
Verified May 2018 by Vidac Pharma.
Recruitment status was: Recruiting
First Posted : May 29, 2018
Last Update Posted : May 30, 2018
PharPoint Research, Inc.
Medistat Ltd., Israel
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||January 15, 2019|
|Estimated Study Completion Date :||January 15, 2019|